Adam Feuerstein

STAT News

Adam Feuerstein is the senior biotech columnist at STAT News, known for his sharp analysis of biotech data, clinical trials, and corporate leadership.

CITERANK · AUTHORITY ACROSS AI ENGINES

AI-cited voice

◆ FREE

855 followers

CiteRank

Estimated · single engine (Perplexity)As measured on 25 Jul 2026

ANSWER SHARE—

CITATION POTENTIAL—

CLAIM THIS PROFILEAre you Adam? Verify to manage your CiteRank.

INTELLECTUAL PROFILEDERIVED FROM PUBLISHED WORK

WHAT MAKES THIS VOICE DISTINCT

Adam Feuerstein's voice is distinctive in its critical and provocative approach to biotech industry news, often highlighting controversies and contradictions. He pushes a recurring angle of scrutinizing biotech companies' performance and financial dealings, as seen in his posts about Sarepta Therapeutics' layoffs and executive promotions. This approach sets him apart from more neutral or promotional voices in the industry.

biotech-techbioTone: analytical-provocativePOV strength 8/10

short opinion takes

news summaries with analysis

promotional posts for own content

HOW THIS VOICE SHOWS UP

+names concrete companies and executives

+opens with personal anecdotes and invitations for discussion

+uses informal language and humor

TOPICS THEY OWN

◆Biotech & techbio

SHARE OF VOICENAMED IN 1 TOPIC · AVG 2.0% · BEST #24

Of all the names AI gives for a topic, the share that goes to this voice. Measured on prompts that don't mention anyone by name.

TOPICSHAREPOSITIONENGINES

Biotech & techbio

named as "Adam Feuerstein"

2.0%#24 of 26NaN

POSITIONS ON NARRATIVES

Not yet appearing in any tracked narrative. As this voice is cited across AI answers, their positions will surface here.

Is this you? Request a correction, dispute the score, or ask to be removed. No account needed.